GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC-M) » Definitions » EV-to-EBIT

Erech Finance Cahalacha (XTAE:EFNC-M) EV-to-EBIT : -1.62 (As of Sep. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Erech Finance Cahalacha's Enterprise Value is ₪20.68 Mil. Erech Finance Cahalacha's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-12.73 Mil. Therefore, Erech Finance Cahalacha's EV-to-EBIT for today is -1.62.

The historical rank and industry rank for Erech Finance Cahalacha's EV-to-EBIT or its related term are showing as below:

XTAE:EFNC-M' s EV-to-EBIT Range Over the Past 10 Years
Min: -39.43   Med: 0.1   Max: 513.91
Current: -1.63

During the past 11 years, the highest EV-to-EBIT of Erech Finance Cahalacha was 513.91. The lowest was -39.43. And the median was 0.10.

XTAE:EFNC-M's EV-to-EBIT is ranked worse than
100% of 451 companies
in the Medical Devices & Instruments industry
Industry Median: 18.37 vs XTAE:EFNC-M: -1.63

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Erech Finance Cahalacha's Enterprise Value for the quarter that ended in Jun. 2024 was ₪22.39 Mil. Erech Finance Cahalacha's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-12.73 Mil. Erech Finance Cahalacha's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -56.85%.


Erech Finance Cahalacha EV-to-EBIT Historical Data

The historical data trend for Erech Finance Cahalacha's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha EV-to-EBIT Chart

Erech Finance Cahalacha Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.87 433.32 42.10 -1.98 -1.55

Erech Finance Cahalacha Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.98 - -1.55 -

Competitive Comparison of Erech Finance Cahalacha's EV-to-EBIT

For the Medical Devices subindustry, Erech Finance Cahalacha's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's EV-to-EBIT falls into.



Erech Finance Cahalacha EV-to-EBIT Calculation

Erech Finance Cahalacha's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=20.682/-12.728
=-1.62

Erech Finance Cahalacha's current Enterprise Value is ₪20.68 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Erech Finance Cahalacha's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-12.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Erech Finance Cahalacha  (XTAE:EFNC-M) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Erech Finance Cahalacha's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-12.728/22.38942528
=-56.85 %

Erech Finance Cahalacha's Enterprise Value for the quarter that ended in Jun. 2024 was ₪22.39 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Erech Finance Cahalacha's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-12.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Erech Finance Cahalacha EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha Headlines

No Headlines